IngeniGen is a China-based company that develops a clinical microbial sequencing and biological information analysis system. The company provides commercial microbial gene database and PCR products for the precision diagnostics of infectious diseases.
Missing: IngeniGen's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: IngeniGen's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing IngeniGen
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
IngeniGen is included in 4 Expert Collections, including Digital Health.
Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.
Companies involved in the capture, sequencing, and/or analysis of genomic, transcriptomic, proteomic, and/or metabolomic data
IngeniGen Frequently Asked Questions (FAQ)
When was IngeniGen founded?
IngeniGen was founded in 2014.
Where is IngeniGen's headquarters?
IngeniGen's headquarters is located at Shaoxing.
What is IngeniGen's latest funding round?
IngeniGen's latest funding round is Series A.
Who are the investors of IngeniGen?
Investors of IngeniGen include Xiran Capital, Jisu Capital, Jiyou Investment and Ruichuang Bio.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.